锦欣生殖(01951.HK)12月8日耗资1484.9万港元回购592.9万股
JXRJXR(HK:01951) Ge Long Hui·2025-12-08 13:18

Core Viewpoint - Jinxin Reproductive Medicine (01951.HK) announced a share buyback on December 8, 2023, spending HKD 14.849 million to repurchase 5.929 million shares at a price range of HKD 2.47 to HKD 2.58 per share [1] Summary by Category - Company Actions - The company executed a buyback of 5.929 million shares, indicating a strategic move to enhance shareholder value [1] - The total expenditure for the buyback was HKD 14.849 million, reflecting the company's commitment to returning capital to shareholders [1] - Share Price Information - The repurchase price per share ranged from HKD 2.47 to HKD 2.58, which may suggest the company's valuation perspective on its own shares [1]